All News

Stop repeating the #ANA test! 46% of all ANA tests were repeat tests in this study. #HealthCareCost #NoUtility #ChooseWisely abst#1278 @rheumnow #ACR22 https://t.co/K7oyqJYvi9

ANA Testing Practices in the United States: A Population-Based Study Between 20…

#ACR22 Advancing Telemedicine in Rheumatology '60% prefer telemedicine for routine visits and review lab results' https://t.co/HUgoocXodE @RheumNow #ACR22

https://onlinelibrary.wiley.com/doi/epdf/10.1002/acr.24860

Did you know that the first virus, the tobacco mosaic virus, was described in 1892? @AdamJBrownMD gave a fascinating lecture today regarding that included the history of viruses. #ACR22 @RheumNow

Do you know the 3 types of Y. Pestis plague? @AdamJBrownMD reviews the Bubonic, Pneumonic, and Septicemia plagues at #ACR22 @RheumNow. Most recently, there was an outbreak of Pneumonic plague in Madagascar in the 2010s!

MEFV mutation protected against the plague. Protected against deactivation of inflammasome by yersinia pestis. @RheumNow #ACR22 #rheuminations https://t.co/OqBay6Svdb

☝️Remember: Not all skin thickening is SSc! 🔸Lipodermatosclerosis is a differential. Has an inverted champagne bottle appearance - caused by venous stasis and venous HTN #ACR22 @RheumNow #Scleroderma #RheumTwitter https://t.co/joWWn6BnVC

🧨Late breaking abstract🧨 #ACR22 @RheumNow #ACRbest Identifying fetal myocardial targets in congenital heart block (CHB) Abstract #L13 🫀maternal serum underwent mass spec. that identified Ab to 4 protein targets that predicted CHB including anti-ATP1A1 as early as 7w

Abstr #0195 examined acceptance of Virtual Reality among pts w/ rheumatic diseases (RD) - VR naïve & experienced were willing to use VR to manage their RD - VR experienced pts had ↑ % of perceived usefulness & anticipated enjoyment of VR in dx and mgmt of RD @RheumNow #ACR22 https://t.co/r7X8Kqp8UN

Keynote lecture from Abraham Varghese at #ACR22 @RheumNow Opening Session Physicians and Patients ◦ Physical examination is meaningful and cannot be replaced by technology ◦ Don’t treat the EHR, treat the patient ◦ Acknowledge how much goes into patient care by our nurses https://t.co/piV0O8O7Hw

Medicare will cover #DXA testing for these diagnoses ⁦@RheumNow⁩ #acr22 #acrreview https://t.co/keZg0fxyz9

Here's a nice slide comparing Sjogren's disease and Sarcoidosis: #ACR22 @RheumNow #acrreview #MedTwitter https://t.co/MQQx3GBl5f

Sialadenosis is a mimic of #sjogren - it related to fatty infiltration/metabolic syndrome. Correct underlying issue and pts will improve - Dr S McCoy @rheumnow #acrreview #acr22 https://t.co/bZPj1LmERs

Wonderful slide by Dr. Sarah McCoy on #Sjogrens #ACR22 @RheumNow Broad differential for these patients when they present in clinic: 📍Ask about: 🚬 habits 💊 meds 🍬 🩻history: #diabetes, past radiation exposure 🦠 infection (#HIV, #HCV) 🩸 #vitamin deficiency https://t.co/6Qo23lWBs4

Dr. Tikly discusses the solutions to drug access challenges in South Africa in both state and private sectors 👇 🔸Off label use, buyouts, price⬇️, advocacy... Highly relatable because these are similar challenges we face in the PH @rheumarhyme @doktora_ging #ACR22 @rheumnow https://t.co/ajshylgtIE

Sleep Habits study from NHANES - 9004 adults >20 yrs (2017-2020) finds mean sleep duration 7.6 hrs on workdays & 8.2 hrs on free days; 23% slept <7 hrs & 25% went to bed > midnight. Nearly 30% had trouble sleeping (daytime sleepiness 27%) https://t.co/Uc7nL4q3fm https://t.co/qvCwqbsez1

https://bit.ly/3WM9AIv

Video Telehealth Willingness Increased During Pandemic Americans’ willingness to use video telehealth has increased since the beginning of the pandemic, rising most sharply among Black Americans and people with less education, according to a new study. https://t.co/oi3C2A7yJt https://t.co/H8AhiXeU3r

https://bit.ly/3hfZvTJ

Celebrating my 10,000 followers on TikTok. @Rheum101 is where I make videos teaching rheumatology to the general public in 3 min bites. Topics include #SLE #Steroids #RA #ANA #RheumLabs #DMARDS #biologics #JAKi #osteoporosis #PsA and more #RheumEducation #NotMedicalAdvice https://t.co/WEXspp5v28

Efficacy of Shingrix Vaccine lasts for 10 yrs. Shingrix was approved in 2017 based on 2 Lg RCTs showing 6 yr. protective efficacy of 97% (ages>50) * 91% (age >70). Long-term F/U shows 81.6% effectfor mean of 9.6 (±0.3) years post-vaccination https://t.co/qCHZ4fUm35 https://t.co/LfYROtN1xZ

https://bit.ly/3gxAlj2

Arthritis Clinical Trials Comparison Grid Use this resource to keep track of your clinical trials and key information needed when communicating with patients about a drug study. https://t.co/9z42zfr1Fx https://t.co/dYAjOVvTaW

https://bit.ly/3CEDqoT